Xueqing Jia

Xueqing Jia

Auto-generated profile, based on publicly available information

Xueqing Jia

Center for Clinical Big Data and Analytics Second Affiliated Hospital, Department of Big Data in Health Science School of Public Health, Zhejiang Key Laboratory of Intelligent Preventive Medicine, Zhejiang University School of Medicine , Hangzhou 310058

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2024 in Advanced Science
Verified
Journal Article
Open access
XJXueqing Jia
Xueqing Jia
JFJiayao Fan
Jiayao Fan
XWXucheng Wu
Xucheng Wu
XCXingqi Cao
Xingqi Cao
LMLina Ma
Lina Ma
ZLZuyun Liu
Zuyun Liu
Existing metabolomic clocks exhibit deficiencies in capturing the heterogeneous aging rates among individuals with the same chronological age. Yet, the modifiable and non‐modifiable factors in metabolomic aging have not been systematically studied. Here, a new aging measure—MetaboAgeMort—is developed using metabolomic profiles from 239,291 UK Biobank participants for 10‐year all‐cause mortality prediction. The MetaboAgeMort showed significant associations with all‐cause mortality, cause‐specific mortality, and diverse incident diseases. Adding MetaboAgeMort to a conventional risk factors model improved the predictive ability of 10‐year mortality. A total of 99 modifiable factors across seven categories are identified for MetaboAgeMort. Among these, 16 factors representing pulmonary function, body composition, socioeconomic status, dietary quality, smoking status, alcohol intake, and disease status showed quantitatively stronger associations. The genetic analyses revealed 99 genomic risk loci and 271 genes associated with MetaboAgeMort. The tissue‐enrichment analysis showed significant enrichment in liver. While the external validation of the MetaboAgeMort is required, this study illuminates heterogeneous metabolomic aging across the same age, providing avenues for identifying high‐risk individuals, developing anti‐aging therapies, and personalizing interventions, thus promoting healthy aging and longevity.

22 April 2026 in Protein & Cell
Verified
Journal Article
Open access
JYJiening Yu
Jiening Yu
DFDuoduo Fu
Duoduo Fu
XWXucheng Wu
Xucheng Wu
WGWeijing Gao
Weijing Gao
HCHongwei Chen
Hongwei Chen
ZLZuyun Liu
Zuyun Liu